retatrutide clinical trial updates parkinson's disease drug therapies in the pipeline: 2024 update Triple hormone receptor agonist retatrutide – Eli Lilly infiltrates anti-obesity market
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 20 - Nov 25






























